Page 5 - Louism Weiner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Louism weiner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Louism Weiner Today - Breaking & Trending Today

Jounce Therapeutics (NASDAQ:JNCE) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research note published on Friday morning. The brokerage issued a hold rating on the stock. Several other analysts also recently commented on the stock. Sumitomo Mitsui Financial Group reaffirmed a neutral rating on shares of Jounce Therapeutics in a report on […] ....

United States , United Kingdom , Jamesp Allison , Robert Schreiber , Piper Sandler , Kevinc Tang , Padmanee Sharma , Louism Weiner , Thomasf Gajewski , Raymond James , Sumitomo Mitsui Financial Group , Millennium Management , Securities Exchange Commission , Capital Management , America Corp , Jounce Therapeutics Company Profile , Jounce Therapeutics Inc , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Exchange Commission , Director Richard , Jounce Therapeutics Daily , Nasdaq Jnce , Initiated Coverage , Stocknews Com ,

Jounce Therapeutics (NASDAQ:JNCE) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research note released on Thursday. The firm issued a hold rating on the stock. JNCE has been the topic of a number of other research reports. Raymond James downgraded shares of Jounce Therapeutics from an outperform rating to a market perform […] ....

United Kingdom , United States , United Kingdom General , Louism Weiner , Kevinc Tang , Piper Sandler , Raymond James , Padmanee Sharma , Robert Schreiber , Jamesp Allison , Thomasf Gajewski , Sumitomo Mitsui Financial Group , Millennium Management , America Corp , Jounce Therapeutics Inc , Securities Exchange Commission , Blackrock Inc , Health Sciences , Jounce Therapeutics , Get Rating , Therapeutics Trading Down , Director Richard , Exchange Commission , Jounce Therapeutics Daily , Nasdaq Jnce , Initiated Coverage ,

Jounce Therapeutics (NASDAQ:JNCE) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com began coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” rating on the stock. JNCE has been the topic of a number of other reports. Piper Sandler lowered shares of Jounce Therapeutics from an […] ....

United Kingdom , Robert Schreiber , Louism Weiner , Raymond James , Padmanee Sharma , Thomasf Gajewski , Kevinc Tang , Piper Sandler , Jamesp Allison , Sumitomo Mitsui Financial Group , Health Sciences , Squarepoint Ops , Jounce Therapeutics Inc , Securities Exchange Commission , Jounce Therapeutics Company Profile , Wealth Group , Balyasny Asset Management , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Therapeutics Trading Down , Exchange Commission , Director Richard , Asset Management , Jounce Therapeutics Daily , Nasdaq Jnce ,

Analysts Set Jounce Therapeutics, Inc. (NASDAQ:JNCE) PT at $8.00

Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) has earned an average rating of “Hold” from the six research firms that are covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 12 month price objective among analysts […] ....

United Kingdom , United States , Louism Weiner , Thomasf Gajewski , Jamesp Allison , Padmanee Sharma , Raymond James , Robert Schreiber , Kevinc Tang , Piper Sandler , Balyasny Asset Management , Sumitomo Mitsui Financial Group , Jounce Therapeutics Inc , Renaissance Technologies , American International Group Inc , Jounce Therapeutics , Get Rating , Marketbeat Ratings , Mitsui Financial Group , Asset Management , International Group , Jounce Therapeutics Daily , Nasdaq Jnce ,

StockNews.com Begins Coverage on Jounce Therapeutics (NASDAQ:JNCE)

StockNews.com started coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research note published on Wednesday. The brokerage issued a hold rating on the stock. Several other equities research analysts have also commented on the stock. Sumitomo Mitsui Financial Group reissued a neutral rating on shares of Jounce Therapeutics in a research […] ....

United Kingdom , United States , Piper Sandler , Padmanee Sharma , Raymond James , Thomasf Gajewski , Robert Schreiber , Louism Weiner , Kevinc Tang , Jamesp Allison , Renaissance Technologies , Jounce Therapeutics Company Profile , Sumitomo Mitsui Financial Group , Balyasny Asset Management , American International Group Inc , Jounce Therapeutics Inc , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Asset Management , International Group , Jounce Therapeutics Daily , Nasdaq Jnce , Initiated Coverage , Stocknews Com ,